Uncommon Presentation of COVID-19 in Pediatric Patients: Anosmia

Basit Öğe Kaydı
dc.contributor.authorDagli, Hatice Y.
dc.contributor.authorAkcan, Ozge M.
dc.contributor.authorPekcan, Sevgi
dc.contributor.authorGenceli, Mustafa
dc.contributor.authorOzdemir, Huseyin S.
dc.contributor.authorUgurlu, Betul
dc.contributor.authorOzbek, Ummu S.
dc.date.accessioned2024-02-23T14:16:59Z
dc.date.available2024-02-23T14:16:59Z
dc.date.issued2021
dc.departmentNEÜen_US
dc.description.abstractObjective The novel coronavirus disease 2019 (COVID-19) infection was declared as a pandemic by the World Health Organization on March 11, 2020. Although the complaint of anosmia is well described in adult patients, there is limited knowledge in pediatric patients. We aim to evaluate the epidemiological characteristics and clinical findings of children with anosmia in COVID-19-positive pediatric patients. Materials and Methods Patients diagnosed with COVID-19 infection at 1 month to 18 years of age, who admitted to Meram Faculty of Medicine of Necmettin Erbakan University between March and June 2020, were retrospectively reviewed, and the patients who had anosmia or developed anosmia during follow-up were then included in the study. The diagnosis was established by polymerase chain reaction (PCR). Results A total of 71 patients were diagnosed with COVID-19 and 14 (19.7%) of them had anosmia. Mean patient age was 14.07 (range: 10-16) years. Six of our 14 (42.8%) patients had anosmia at the time of diagnosis and anosmia developed in the follow-up among eight patients. The mean duration of anosmia in our patients was 6.93.8 days. Recovery time was 1 to 4 days in four patients (28.5%), 5 to 8 days in four patients (28.5%), and 9 to 14 days in six patients (42.8%). Conclusion In this article, it was emphasized that anosmia can be the sole manifestation or concomitant with other symptoms in children with COVID-19 disease. Care and attention is important to identify COVID-19 patients at an early stage of the disease and limit the spread of the virus.en_US
dc.identifier.doi10.1055/s-0041-1723974
dc.identifier.endpage84en_US
dc.identifier.issn1305-7707
dc.identifier.issn1305-7693
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-85101359146en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage80en_US
dc.identifier.urihttps://doi.org/10.1055/s-0041-1723974
dc.identifier.urihttps://hdl.handle.net/20.500.12452/12873
dc.identifier.volume16en_US
dc.identifier.wosWOS:000619250200001en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherGeorg Thieme Verlag Kgen_US
dc.relation.ispartofJournal Of Pediatric Infectious Diseasesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAnosmiaen_US
dc.subjectCovid-19en_US
dc.subjectPolymerase Chain Reactionen_US
dc.subjectChildrenen_US
dc.titleUncommon Presentation of COVID-19 in Pediatric Patients: Anosmiaen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu